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The expression of the human cytomegalovirus (HCMV) UL97 open reading frame in infected or transfected cells in the
presence of the antiherpes compound ganciclovir (GCV) results in the intracellular phosphorylation of GCV. There are
conventional kinase domains within the UL97-encoded protein (pUL97). However, the role of pUL97 in the HCMV replication
cycle, and the mechanism by which it causes phosphorylation of GCV, are currently unknown. Herein, the biosynthesis and
biogenesis of pUL97 was studied in HCMV-infected cells. pUL97 is expressed with early-late kinetics and is posttransla-
tionally modified by phosphorylation. This phosphorylation occurs within 1 hr after synthesis, affects the electrophoretic
mobility of pUL97, and is independent of the presence of other HCMV proteins. pUL97 was localized to the nucleus of
infected cells and found in the HCMV virions. Thus, pUL97 is a virion phosphoprotein, and a likely tegument component.
q 1997 Academic Press
INTRODUCTION virus type 1 (HSV-1), Epstein–Barr virus, varicella-zoster
virus, and human herpesvirus 6 (Chee et al., 1989; Smith
Human cytomegalovirus (HCMV) causes significant
and Smith, 1989). Furthermore, these putative herpesvi-
morbidity and mortality in immunocompromised and im-
rus phosphotransferases are within conserved regions
munosuppressed adults, as well as in congenitally in-
of their respective genomes, being similarly positioned
fected infants (Britt and Alford, 1996). A common treat-
relative to genes which encode the major capsid protein,
ment for HCMV disease is the nucleoside analogue gan-
DNA terminase, and alkaline exonuclease (Lawrence et
ciclovir (GCV). In HCMV-infected cells, the prodrug GCV
al., 1990). Although this may suggest conservation of
is phosphorylated to the active form, GCV triphosphate,
function, since their shared homology is limited to the
a substrate for viral DNA polymerase (UL54), resulting in
recognized kinase domains of these relatively large pro-
inhibition of viral DNA synthesis by slowing elongation
teins (50–80 kDa), Chee et al. (1989) caution against
of viral DNA (Cheng et al., 1983; Biron et al., 1985; Mar et
the conclusion that these phosphotransferases have the
al., 1985; Sullivan et al., 1993; Crumpacker, 1996). HCMV
same specificity or function. Notwithstanding, Ng et al.
isolates resistant to the inhibitory effect of GCV have
(1996) reported recently that UL97 can partially compen-
mutations in either UL54, affecting the polymerase’s affin-
sate for its putative analog in HSV-1, UL13 (Chee et al.,
ity for the drug, or in UL97, which encodes a phospho-
1989), in recombinant UL13 deletion virus. UL13 is known
transferase (Chee et al., 1989; Alain et al., 1993; Littler
to encode a protein kinase which phosphorylates an
et al., 1992; Sullivan et al., 1992). UL97 expression in
HSV-1 immediate-early protein, ICP22 (a22) (Cunning-cells confers the ability to phosphorylate GCV in the ab-
ham et al., 1992; Purves and Roizman, 1992; Purves etsence of other HCMV genes (Littler et al., 1992; Metzger
al., 1993). By analogy, the function of pUL97 may be toet al., 1994). Therefore, UL97 is the only HCMV gene
phosphorylate another HCMV-encoded protein, or per-required for GCV phosphorylation.
haps a cellular protein, but its physiological substrateThe UL97 open reading frame encodes a 707-amino
has not yet been identified.acid protein (pUL97) which possesses conventional ki-
Here, we have examined the biosynthesis and biogen-nase domains within its C-terminal half (Hanks et al.,
esis of pUL97 in HCMV-infected cells. pUL97 is (i) synthe-1988; Chee et al., 1989). When expressed in bacteria,
sized within a few hours of infection and through latethis C-terminal portion of UL97 is sufficient to cause the
times; (ii) posttranslationally modified by phosphorylationphosphorylation of GCV in vitro (Littler et al., 1992). pUL97
within 1 hr of synthesis; (iii) located in the nuclei of in-has amino acid homology with proteins encoded by at
fected cells; and (iv) found in the mature virion. Further-least four other herpesviruses, including herpes simplex
more, experiments performed with cell lines stably ex-
pressing functional pUL97 indicated that phosphorylation
1 To whom correspondence and reprint requests should be ad-
of pUL97 was independent of expression of other viraldressed. Fax: (914) 732-2480. E-mail: vanzeim@war.wyeth.com.
proteins.2 Present address: Ares Advanced Technology Inc., 280 Pond Street,
Randolph, MA 12368. Portions of this manuscript were presented at the 21st
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International Herpesvirus Workshop, Dekalb, IL, 27 July – kDa band corresponding to UL97 protein was cut from
the gel, eluted, and used to immunize female New1 August, 1996.
Zealand white rabbits (Pocono Rabbit Farm, Canadensis,
PA). Production of antiserum BX49 against the HCMVMETHODS
UL80-encoded assembly protein was described (Jones
DNA sequence
et al., 1994).
The numbering system of Chee et al. (1990) was used
Protein analysisfor the HCMV strain AD169 DNA sequence (Genbank
Accession No. X17403). Metabolic labeling with [35S]methionine/cysteine, im-
munoprecipitation, and immunoblot techniques were
Cells and virus
performed as described (Jones et al., 1994; 1995).
For radiolabeling experiments involving nonradioactiveHCMV AD169 was obtained from the American Type
Culture Collection and propagated in human foreskin fi- chases, radioactive media was removed and replaced
with nonradioactive complete media after two washesbroblast (HFF) cells. HFF cells and U373-MG (U373)
astrocytoma cells were described (Jones et al., 1995). with PBS; incubation was continued until the proper har-
vest time. For phosphate labeling, cells grown on 60-U373-derived cell lines stably expressing UL97 protein
were obtained by transfection of pRcCMVp-UL97 by the mm dishes were washed in phosphate-free media and
labeled with 200 mCi [32P]orthophosphate per millilitercalcium phosphate precipitation method, selected in 0.5
mg/ml puromycin, and cloned as described (Kim et al., (NEN DuPont, Cambridge, MA) in phosphate-free media
(Gibco, Gaithersburg, MD). Cells were then washed twice1995).
in PBS and processed as described for [35S]methionine/
UL97 expression plasmids cysteine-labeled cells (Jones et al., 1994). For phospha-
tase treatment, immunoprecipitates were washed in 50The AD169 UL97 gene (nt 140484 to 142604; Chee et
mM Tris–HCl, pH 7.8, 5 mM DTT, 2 mM MgCl2 , 0.1 mg/al., 1990) was amplified with Taq polymerase (Boehringer
ml BSA, and treated with 800 U lambda-phosphataseMannheim Biochemicals, Indianapolis, IN) from the
(New England Biolabs, Beverly, MA) for 30 min at 307 inAD169 HindIII-S fragment (pHindS; Oram et al., 1982)
the same buffer.with the following primers: 5*GGAATTCATATGTCCTCC-
GCACTTCGGTC3* and 5*GGAATTCTTACTCGGGGAAC-
Virion purification
AGTTGGC3*, introducing a NdeI site at the initiating ATG
and an EcoRI site at both ends of the gene, and cloned The media from a 150-cm2 flask of HFF cells infected
with HCMV at a multiplicity of infection of 5 PFU/cell,into pUC118. The internal AscI fragment (nt 140577 –
141996) was replaced by the corresponding AscI frag- was collected 5 days after infection, cleared by centrifu-
gation for 10 min at 3,000 g at 47, and subjected to twoment from pHindS and the remaining nucleotides were
confirmed by sequencing. The UL97 gene was then rounds of purification over tartrate-glycerol gradients as
described (Talbot and Almeida, 1977; Irmiere and Gib-cloned as a NdeI– EcoRI fragment into the prokaryotic
expression vector, pT7K (Plotch et al., 1989), to yield son, 1983). Bands corresponding to noninfectious enve-
loped particles and virion fractions were collected frompT7K-UL97. For eukaryotic expression, UL97 was placed
under the control of the immediate-early HCMV en- the centrifuge tubes by side puncture after visualization
by light-scattering. Corresponding fractions from 5 gradi-hancer-promoter in pRcCMVp-UL97. Briefly, the UL97-
containing NdeI– EcoRI fragment, along with a linker ents following an initial centrifugation (15 min) were
pooled and applied to a new glycerol-tartrate gradientwhich provided a favorable eukaryotic consensus trans-
lation sequence (Kozak, 1991) (5*AGCTTGGTACCGAGC- and recentrifuged for 18 hr. Bands were collected simi-
larly, diluted to 8 ml with 40 mM sodium phosphate (pHTCGACGCCGCCAC3* and 5*TAGTGGCGGCGTCGACG-
AGCTCGGTACCA3*) were cloned into HindIII/EcoRI-di- 7.4)/100 mM NaCl, and pelleted at 85,000 g for 90 min
at 47. Pellets were resuspended in SDS-gel buffer (Sam-gested pRcCMVp. pRcCMVp was derived from pRcCMV
(Invitrogen, San Diego, CA) by replacing the neomycin- brook et al., 1989) and boiled prior to SDS–PAGE.
resistance gene with the puromycin-resistance gene (de
Immunofluorescencela Luna and Ortin, 1992).
Uninfected and HCMV-infected (multiplicity of infection
Antibodies
of 5 PFU/cell) HFF cells were fixed at 3 days p.i., perme-
abilized, and treated with antibodies as described (KimUL97 synthesis in Escherichia coli strain BL21(lDE3)-
LysS harboring pT7K-UL97 was induced with 1 mM iso- et al., 1995), except that the primary antibody was diluted
1:100, and the secondary antibody was 1:250-dilutedpropyl-b-D-thiogalactopyranoside for 3 hr. After sonica-
tion to lyse the bacterial cells, protein extracts from the FITC-conjugated donkey-anti-rabbit immunoglobulin G
(Pierce, Rockford, IL).pellet fraction were subjected to SDS–PAGE. The 80-
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FIG. 1. Metabolic labeling of pUL97. (a) Uninfected (lanes 1 and 3) or HCMV-infected (lanes 2 and 4) HFF cells were labeled at 3 days p.i. for 4
hr with [35S]methionine/cysteine. Cells were lysed and either preimmune serum (lanes 1 and 2) or UL97 antiserum (lanes 3 and 4) was added,
followed by protein A–Sepharose. Samples were then analyzed by SDS–PAGE followed by autoradiography. The migration of pUL97, pp65, and
an unknown protein of 35–40 kDa are indicated. The positions of molecular weight markers are indicated in kDa. (b) Uninfected (lane 1) or HCMV-
infected (lanes 2–12) HFF cells were pulse-labeled at the indicated times p.i. for 30 min with [35S]methionine/cysteine and chased with excess
unlabeled methionine and cysteine for 0 (lanes 1, 2, 7, and 8), 30 (lanes 3 and 9), 60 (lanes 4 and 10), 90 (lanes 5 and 11), or 120 min (lanes 6 and
12). Cells were lysed and pUL97 immunoprecipitated using UL97 antiserum. Samples were then analyzed by SDS–PAGE followed by autoradiography.
Arrows indicate the range of migration of pUL97.
RESULTS pUL97 in HCMV-infected cells was analyzed by immu-
noblotting, using cell lysates taken at different times after
UL97 antiserum
infection (Fig. 2a). At 5 hr p.i. pUL97 was readily detected;
further accumulation of pUL97 occurred steadily throughThe HCMV AD169 UL97 gene was cloned in a prokary-
otic expression vector and expressed in E. coli; pUL97 late times postinfection. Since trace levels of pUL97 were
present at 2–4 hr p.i., but not in uninfected cells (Figs. 2awas excised from a SDS –PAGE gel and injected into a
rabbit for antibody production. The antiserum was tested and 2b), viral particles twice purified on glycerol-tartrate
gradients were analyzed for the presence of pUL97 (Fig.for specificity by immunoprecipitation using radiolabeled
lysates from HCMV-infected and uninfected HFF cells 2c). pUL97 protein was detected both in noninfectious
enveloped particles (Irmiere and Gibson, 1983; 1985) and(Fig. 1a). Besides the expected band corresponding to
pUL97, two additional proteins were observed in immu- virions, which comigrated with pUL97 from infected cells.
Thus, the data from Fig. 2, as well as results of metabolicnoprecipitations using late infected-cell lysates (lane 4).
These proteins are observed when using all rabbit anti- radiolabeling-immunoprecipitation experiments (see be-
low), indicate that pUL97 is synthesized throughout mostsera (data not shown) and are nonspecifically precipi-
tated, as evidenced by their precipitation with preimmune of the replication cycle and is a virion constituent. Fur-
thermore, the trace levels of pUL97 detected at 2–4 hrserum (lanes 1 and 2) and with normal human serum
(data not shown). The protein of approximately 65 kDa p.i. represent protein which entered the cell with the
virion and not de novo protein synthesis, since similaris believed to be pp65, an abundant HCMV late protein.
The nature of the 35- to 40-kDa protein is unknown. The levels of pUL97 were detected in the presence of protein
synthesis inhibitors (data not shown). Pulse–chase ex-80-kDa UL97 protein was the only protein uniquely
precipitated by the immune serum (lane 4), demonstra- periments at both early and late times postinfection indi-
cated that pUL97 is stable, with no detectable turnoverting the specificity of the UL97 antiserum.
after an 8-hr chase (data not shown).
Expression and virion localization of pUL97
Intracellular localization
Protein expression from UL97 was analyzed using
polyclonal antiserum obtained from rabbits immunized Hydropathy analysis of UL97 protein does not predict
any hydrophobic domains large enough to provide awith pUL97 expressed in E. coli. The accumulation of
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or 120 min followed by immunoprecipitation with UL97
antiserum (Fig. 1b). pUL97 pulse-labeled at both early (6
hr p.i.; lane 2) and late (48 and 72 hr p.i.; lanes 7 and 8)
times p.i. migrated as a single band of approximately 80
kDa, but its electrophoretic mobility was substantially
retarded after a 60-min or longer chase (lanes 4–6 and
10–12). The electrophoretic mobility of pUL97 was re-
tarded to an intermediate level after a 30-min chase
FIG. 2. pUL97 expression in infected cells and purified virions. (a)
Uninfected (lane 1) or HCMV-infected HFF cells lysed at 2, 3, 4, 5,
6, 10, 24, 48, 72, or 96 hr p.i. (lanes 2 – 11) were subjected to SDS –
PAGE and analyzed by immunoblotting with UL97 antiserum. The
location of pUL97, which has a heterogeneous mobility, is indicated.
(b) A darker exposure of part of panel a, demonstrating the presence
of pUL97 at 2 – 4 hr p.i. (c) Noninfectious enveloped particles (NIEPs;
lane 1) and virions (lane 2) were purified twice by centrifugation
through glycerol – tartrate gradients and analyzed by Western blot-
ting. A lysate from HCMV-infected HFF cells (72 hr p.i.) was loaded
for comparison (lane 3).
transmembrane domain (data not shown). Since pUL97
is present in virions, it is probably located in the tegument
or capsid, which assemble in the nucleus of infected
cells (Roizman and Sears, 1993; Ward et al., 1996). There-
fore, pUL97 is predicted to localize to the nucleus. This
prediction was confirmed by indirect immunofluores-
cence using UL97 antiserum (Fig. 3). Although cyto-
plasmic fluorescence of infected cells by UL97 antiserum
was slightly increased relative to that observed with pre-
immune serum (Figs. 3a and 3b), pUL97 localized pre-
dominantly to the nucleus (Fig. 3b).
Posttranslational modification
It was observed from immunoblot analysis that pUL97
migrates heterogeneously in SDS–PAGE; this is espe-
cially evident at late times p.i. when relatively abundant
steady-state levels of pUL97 are present (Fig. 2a, lanes
10 and 11). Although the data in Fig. 2 were from labora-
tory strain AD169-infected cells, identical results con-
cerning pUL97 abundance and heterogeneity were ob-
tained in experiments utilizing clinical isolates of HCMV
(data not shown). To investigate whether this heteroge-
FIG. 3. Subcellular localization of pUL97. HCMV-infected HFF cellsneity was due to posttranslational modification, pUL97
at 3 days p.i. (a and b) or uninfected HFF cells (c) were analyzed bywas examined in a pulse–chase radiolabeling-immuno-
indirect immunofluorescence using either preimmune serum (a) orprecipitation experiment (Fig. 1b). HCMV-infected HFF
UL97-specific antiserum (b and c). Prior to incubation with rabbit sera,
cells were pulse-labeled for 30 min with [35S]methionine/ cells were exposed to normal human serum to eliminate detection of
cysteine at different times p.i. and chased in the pres- nonspecific binding of rabbit immunoglobulins to uninfected or infected
cell proteins. Bar is 25 mm.ence of unlabeled methionine and cysteine for 30, 60, 90,
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the electrophoretic mobility shift we observed within
1 hr after synthesis. pUL97 metabolically labeled with
[35S]methionine/cysteine was immunoprecipitated from
HCMV-infected cells and treated with lambda-phospha-
tase (under conditions which should remove phosphate
on serine, threonine, and tyrosine residues), and ana-
lyzed by SDS–PAGE (Fig. 5). pUL97 continuously labeled
for 4 hr, or pulse-labeled for 30 min and chased for 90
min, had an increased electrophoretic mobility after
phosphatase treatment (lanes 2 and 6) as compared to
the corresponding untreated samples (lanes 1 and 5);
however, they had an electrophoretic mobility equal to
that of the untreated 30-min pulse samples (lanes 3 and
7). Phosphatase treatment of the 30-min pulse sample
did not alter the electrophoretic mobility of pUL97 (lanes
4 and 8). Taken together, the data indicate that withinFIG. 4. pUL97 is phosphorylated. Uninfected (‘‘0’’) or infected HFF
the 30-min pulse, pUL97 did not acquire phosphate yet.cells (‘‘/’’) were labeled for 4 hr with [35S]methionine/cysteine (lanes
1– 6) or for 16 hr with [32P]i (lanes 7–12) and lysed at indicated times However, by 1 hr after the pulse, pUL97 became phos-
postinfection. pUL97 (lanes 1– 3 and 7–9) or assembly protein (AP; phorylated resulting in decreased electrophoretic mobil-
lanes 4–6, and 10–12) were immunoprecipitated with the respective ity relative to unphosphorylated pUL97. Other phospha-
antisera and analyzed by SDS– PAGE followed by autoradiography. The
tases were also used (protein-phosphatase 1, 2A, andanti-AP antiserum (BX49) precipitates bands of 80 and 85 kDa, both
2B) but, at best, resulted in only partial dephosphorylationprotease-precursors (Jones et al., 1994), and 44 (pre-AP) and 37 kDa
(AP). The positions of pUL97 and pre-AP and AP are indicated. The of pUL97 (data not shown).
band at approximately 68 kDa in lanes 3, 6, 9, and 12 is a nonspecifically
immunoprecipitated late viral phosphoprotein, probably pp65. Phosphorylation of pUL97 does not require other viral
proteins
(lanes 3 and 9). Thus, pUL97 is posttranslationally modi- pUL97 was examined in the absence of other viral
fied within 1 hr after synthesis. proteins by construction of U373-derived cell lines which
constitutively express UL97 under the control of the
pUL97 is phosphorylated HCMV major immediate-early enhancer-promoter. Multi-
ple cell lines were obtained, two of which, 97-7 and 97-To investigate the nature of the apparent molecular
8, were studied (Fig. 6). Immunoblot analysis revealedweight increase, pUL97 was examined for the presence
a UL97-reactive protein which comigrated with pUL97of glycosylation and phosphorylation. There was no indi-
obtained from CMV-infected cells (Fig. 6a). This proteincation that pUL97 was glycosylated, since we were un-
was not observed in cell lines obtained after transfectionable to detect incorporation of radiolabeled galactose or
with the empty vector (i.e., cell line Rcp). pUL97 ex-glucose into pUL97 (data not shown). Possible phosphor-
pressed in 97-7 and 97-8 cell lines was shown to beylation of pUL97 was examined by metabolic labeling of
HCMV-infected HFF cells with [32P]i at 25 or 74 hr p.i.
followed by immunoprecipitation with UL97 antiserum
(Fig. 4). As a positive control, UL80-encoded proteins
containing the C-terminal assembly protein domain were
immunoprecipitated with BX49 antiserum (Jones et al.,
1994). In addition to the 80- and 85-kDa protease precur-
sor proteins, the 44-kDa assembly protein precursor and
the 37-kDa mature assembly protein are recognized by
antiserum BX49. As shown in Fig. 4 (lanes 10–12), all
assembly protein species were phosphorylated, as
shown previously (Roby and Gibson, 1986). pUL97 was FIG. 5. Treatment with lambda-phosphatase removes phosphate
likewise labeled with [32P]i , and continued to migrate from pUL97. pUL97 immunoprecipitated from HCMV-infected HFF cells,
which were previously labeled at 72 hr p.i. for 4 hr (lanes 1 and 2) orheterogeneously (Fig. 4, lanes 8 and 9). As further evi-
pulse-labeled for 30 min (lanes 3, 4, 7, and 8) with [35S]methionine/dence that pUL97 is a phosphoprotein 32P-labeled pUL97
cysteine followed by a 120-min chase (lanes 5 and 6), were treatedwas treated with lambda-phosphatase, which removed
with lambda-phosphatase (‘‘/’’) or mock-treated (‘‘0’’). The positions of
all label from the protein (data not shown). the phosphorylated (top band) or dephosphorylated (bottom-band)
pUL97 was digested with lambda-phosphatase to de- forms of pUL97 are indicated. A nonspecifically precipitated late viral
protein is indicated (*).termine whether phosphorylation was responsible for
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FIG. 6. Phosphorylation of pUL97 does not require other viral proteins. (a) Immunoblot analysis of proteins from U373-derived cell lines stably
expressing pUL97 (97-7 and 97-8, lanes 2 and 3), empty vector control cells (Rcp, lane 1) together with late HCMV-infected HFF cells (72 hr p.i.;
lane 4). (b) Rcp, 97-7, and 97-8 cell lines were labeled for 16 hr with [35S]methionine/cysteine, pUL97 was immunoprecipitated and treated with
lambda-phosphatase (‘‘/’’ ; lanes 2, 4, and 6) or mock-treated (‘‘0’’ ; lanes 1, 3, and 5). Immunoprecipitates were then analyzed by SDS–PAGE
followed by autoradiography. The arrowhead indicates the dephosphorylated form of pUL97, which migrates slightly faster than the phosphorylated
form.
functional since growth of a thymidine kinase negative acids) deletions within domains not conserved among
protein kinases (Chou et al., 1995; Sullivan et al., 1992).(tk0) mutant of HSV-1 (Jones et al., 1991) in these cells
was inhibited in the presence of GCV; there was no inhi- This is in contrast with the HSV-1 thymidine kinase gene,
which is responsible for the phosphorylation of GCV andbition of HSV-1 tk0 virus growth in the presence of GCV
in Rcp cells (data not shown). Similar to HCMV-infected acyclovir (Fyfe et al., 1978), but is not essential for virus
growth in tissue culture (Efstathiou et al., 1989). As acells, pUL97 immunoprecipitated from 97-7 and 97-8
cells, after metabolic labeling with [32P]i , contained la- prelude to studies concerning the physiological role of
UL97 in HCMV replication, the expression of UL97 inbeled phosphate (data not shown). In addition, the migra-
tion of pUL97 in SDS–PAGE after phosphatase treatment HCMV-infected cells was examined. Herein, we report
that pUL97 is synthesized throughout most of the replica-(Fig. 6b) was examined. Like pUL97 from HCMV-infected
cells, pUL97 from the cell lines was sensitive to treatment tive cycle, is posttranslationally modified by phosphoryla-
tion, and is a component of HCMV virions.with lambda-phosphatase, as indicated by its increased
electrophoretic mobility (lanes 4 and 6). These results Our initial observation that pUL97 was posttransla-
tionally modified was due to its heterogeneous electro-indicate that phosphorylation of pUL97 does not require
the presence of other HCMV gene products and is there- phoretic mobility (Fig. 2). Several proteins are affected in
their mobility in SDS–PAGE by phosphorylation. Thefore the result either of phosphorylation by cellular ki-
nases or of autophosphorylation. SV40 large T antigen is phosphorylated on many resi-
dues, but only the phosphorylation of threonine 124 or
701 increases its electrophoretic mobility (Gra¨sser andDISCUSSION
Konig, 1992). In contrast, the EBNA 2A protein of Epstein–
The HCMV UL97 gene plays a central role in conferring Barr virus shows a decrease in mobility upon phosphory-
sensitivity to GCV since it is responsible for the initial lation (Gra¨sser et al., 1991). We found that within 1 hr
phosphorylation of GCV to GCV-monophosphate (GCV- after synthesis all pUL97 was phosphorylated and this
MP) which leads to the full phosphorylation of GCV-MP phosphorylation was completely responsible for the ob-
by cellular nucleoside kinases to the active GCV-triphos- served decrease in electrophoretic mobility of the pro-
phate (Biron et al., 1985; Littler et al., 1992; Sullivan et tein. Phosphorylation of pUL97 also occurred in cells that
al., 1992). The role of the UL97 gene in viral replication, expressed it in the absence of other viral proteins, which
however, is not clear. It is thought that UL97 plays an indicated that pUL97 was phosphorylated either by a
essential role in viral replication based on the following: cellular kinase or by autophosphorylation (Fig. 6). He et
(i) UL97 has homology to genes of other herpesviruses al. (1996) recently reported the in vitro autophosphoryla-
and is located within the conserved region of herpesvirus tion of recombinant pUL97, produced in insect cells, on
genomes containing capsid morphogenesis and DNA serine and threonine residues. These authors reported
processing functions (Chee et al., 1989; Lawrence et al., that inactivation of enzymatic activity by mutation of an
1990); (ii) efforts to isolate a virus with a deletion of the active site residue did not completely abolish the incor-
UL97 gene have failed (Michel et al., 1996), and (iii) GCV- poration of radioactive phosphate into pUL97, indicating
resistant HCMV isolates with mutations in the UL97 gene that cellular kinases may also contribute to the total
phosphorylation of pUL97. Lambda-phosphatase re-contain point mutations or, at most, small (four amino
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moves phosphate from serines and threonines and, at component of newly infected cells, pUL97 may perform
an important role during the immediate-early phase ofhigher concentrations of enzyme, also from tyrosine resi-
dues. Here we used lambda-phosphatase in amounts HCMV replication. For example, the HSV-1 UL13 kinase,
a homologue of UL97 (Chee et al., 1989), is expressedsufficient to remove phosphate from serine, threonine,
and tyrosine residues. Other phosphatases, with more abundantly at late times and is a component of the HSV-
1 virions (Overton et al., 1992). ICP22, an immediate-limited substrate specificity, were unable to completely
remove phosphate from pUL97, indicating either that the early protein, has been identified as a substrate of UL13
protein kinase (Purves and Roizman, 1992). The phos-phosphate(s) on pUL97 were not accessible to these
phosphatases or that the amino acid sequence sur- phorylation of ICP22 is important for replication of HSV-
1 in rodent cell lines (Purves and Roizman, 1992; Purvesrounding the phosphorylation site do not conform to the
recognition specificity of these phosphatases. et al., 1993). Another HCMV virion component, the pp65
tegument phosphoprotein, which is a presumed kinaseDe novo synthesis of pUL97 begins at 5 hr p.i. and
continues through the remainder of the replicative cycle, (Britt and Auger, 1986, Michelson et al., 1984), but is
nonessential for HCMV replication (Schmolke et al.,with relatively high steady state levels of pUL97 at late
times p.i. (Fig. 2). The appearance of newly synthesized 1995), has a role at immediate-early times after infection.
This phosphoprotein, encoded by UL83 with early-latepUL97 was in agreement with the onset of UL97 tran-
scription as reported by Wing and Huang (1995), consis- expression kinetics (Depto and Stenberg, 1989), is intro-
duced into cells by the infecting virions and functions attent with the grouping of UL97 in the class of early-late
genes. In contrast to data reported by Michel et al. (1996) immediate-early times to eliminate presentation of the
immediate-early IE1 protein at the cell surface by causingwho detected pUL97 in HCMV-infected cells beginning
at 16 hr p.i. by immunoblotting, pUL97 synthesis was the phosphorylation of that protein (Gilbert et al., 1996).
The HCMV tegument phosphoprotein pp71, encoded bydetected as early as 5 hr p.i. in our experiments. This
apparent discrepancy could be explained by qualitative UL82, has been recognized as playing an important role
in the transcriptional stimulation of immediate-earlyand quantitative differences in the antibodies used. Trace
levels of pUL97 were detected in infected cells prior to genes (Liu and Stinski, 1992). The above-mentioned tegu-
ment proteins all have important functions in viral replica-5 hr p.i., consistent with the presence of pUL97 in mature
virions. Further experiments have revealed that pUL97 tion; it is conceivable that pUL97 also has such a regula-
tory role. Consistent with an important role in the infec-detected from 2 to 4 hr p.i. entered the cells as a compo-
nent of the infecting virions (data not shown). tion cycle is that UL97 deletion mutants could not be
purified (Michel et al., 1996). Thus, elucidation of thepUL97 is likely to be localized to the tegument of the
HCMV virion, since hydropathy analysis of pUL97 does function of pUL97 in the HCMV replication cycle may
depend on the generation of UL97 conditional lethal ornot reveal any region likely to be a transmembrane do-
main, and pUL97 does not correspond to the HCMV ana- host range viral mutants (Kim et al., 1995; Compton,
1993). The degree to which phosphorylation of pUL97log of known herpesvirus capsid proteins (Gibson end
Roizman, 1972; Cohen et al., 1980; Chee et al., 1990; may impact its function can be elucidated once its physi-
ological target is identified.Rixon et al., 1990). The localization of pUL97 in the nu-
cleus of infected cells, reported here and recently by
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